Back to Screener
$1.16
Market Cap:
$2M
Investment Snapshot
- Loss-making — negative ROE of -9.3%
CDT Equity Inc. - Common Stock (CDT) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $2 million .
Value Score
35
out of 100
Key Metrics
PEG Ratio
—
P/S Ratio
—
EV/EBITDA
—
ROE
—
ROA
—
Gross Margin
—
Op. Margin
—
Net Margin
—
Debt/Equity
—
Current Ratio
—
Revenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Data sourced from SEC EDGAR and Polygon.io. Methodology.
View more Healthcare stocks →
CDT Equity Inc. - Common Stock — Fundamental Analysis Summary
StockPik's composite Value Score for CDT is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.